Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 174-179

  Miyashita, Michiko ^a   Sadzuka, Yasuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Antitumor activity; Doxorubicin; Influx; Linalool; Nucleoside transporter

Indexed keywords

DOXORUBICIN; LINALOOL; NITROBENZYLTHIOINOSINE; NUCLEOSIDE TRANSPORTER; NUCLEOSIDE TRANSPORTER 3; PHLORIZIN; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG PENETRATION; FOOD DRUG INTERACTION; HUMULUS LUPULUS; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; TREATMENT DURATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; DOXORUBICIN; HUMULUS; LEUKEMIA P388; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED DBA; MONOTERPENES; NEOPLASM TRANSPLANTATION; OILS, VOLATILE; PLANT EXTRACTS;

HUMULUS LUPULUS;

EID: 84871658844     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.035     Document Type: Article

References (33)

1. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., Young J.D. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 2004, 447:735-743.
2. Bazemore R., Rouseff R., Naim M. Linalool in orange juice: origin and thermal stability. J. Agric. Food Chem. 2003, 51:196-199.
3. Budd G.T., Fleming T.R., Bukowski R.M., McCracken J.D., Rivkin S.E., O'Bryan R.M., Balcerzak S.P., Macdonald J.S. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. J. Clin. Oncol. 1987, 5:272-277.
4. Chadwick L.R., Pauli G.F., Farnsworth N.R. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine 2006, 13:119-131.
5. Coldham N.G., Sauer M.J. Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem. Toxicol. 2001, 39:1211-1224.
6. Eri S., Khoo B.K., Lech J., Hartman T.G. Direct thermal desorption-gas chromatography and gas chromatography-mass spectrometry profiling of hop (Humulus lupulus L.) essential oils in support of varietal characterization. J. Agric. Food Chem. 2000, 48:1140-1149.
7. Gatta G., van der Zwan J.M., Casali P.G., Siesling S., Dei Tos A.P., Kunkler I., Otter R., Licitra L., Mallone S., Tavilla A., Trama A., Capocaccia R. RARECARE working group. Rare cancers are not so rare: the rare cancer burden in Europe. Eur. J. Cancer 2011, 47:2493-2511.
8. Gray J.H., Owen R.P., Giacomini K.M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 2004, 447:728-734.
9. Ito Y., Sugimoto A., Kakuda T., Kubota K. Identification of potent odorants in Chinese jasmine green tea scented with flowers of Jasminum sambac. J. Agric. Food Chem. 2002, 50:4878-4884.
10. Kato M., Shibamoto T. Variation of major volatile constituents in various green teas from Southeast Asia. J. Agric. Food Chem. 2001, 49:1394-1396.
11. Kubota T. The role of S-1 in the treatment of gastric cancer. Br. J. Cancer 2008, 98:1301-1304.
12. Linck V.M., da Silva A.L., Figueiró M., Caramão E.B., Moreno P.R., Elisabetsky E. Effects of inhaled Linalool in anxiety, social interaction and aggressive behavior in mice. Phytomedicine 2010, 17:679-683.
13. Lua N.T., Chinh N.D., Hue N.T., Van V.T., Hang L.T., Linh, le T., Boupha B., Sengsounthone L., Sengngam K., Akiba S., Tung H.T., Chuong, le H., Ngoan, le T. Survey-based cancer mortality in the Lao PDR, 2007-08. Asia-Pac. J. Cancer Prev. 2011, 12:2495-2498.
14. Nagasawa K., Fumihara T., Ohnishi N., Yokoyama T. Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells. Jpn. J. Cancer Res. 1999, 90:781-787.
15. Nakamura A., Fujiwara S., Matsumoto I., Abe K. Stress repression in restrained rats by (R)-(-)-linalool inhalation and gene expression profiling of their whole blood cells. J. Agric. Food Chem. 2009, 57:5480-5485.
16. Ngoan Le T., Lua N.T., Hang L.T. Cancer mortality pattern in Viet Nam. Asia-Pac. J. Cancer Prev. 2007, 8:535-538.
17. Nozawa H., Nakao W., Zhao F., Kondo K. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon. Mol. Nutr. Food Res. 2005, 49:772-778.
18. Peana A.T., D'Aquila P.S., Chessa M.L., Moretti M.D., Serra G., Pippia P. (-)-Linalool produces antinociception in two experimental models of pain. Eur. J. Pharmacol. 2003, 460:37-41.
19. Peana A.T., De Montis M.G., Nieddu E., Spano M.T., D'Aquila P.S., Pippia P. Profile of spinal and supra-spinal antinociception of (-)-linalool. Eur. J. Pharmacol. 2004, 485:165-174.
20. Peana A.T., De, Montis M.G., Sechi S., Sircana G., D'Aquila P.S., Pippia P. Effects of (-)-linalool in the acute hyperalgesia induced by carrageenan, l-glutamate and prostaglandin E2. Eur. J. Pharmacol. 2004, 497:279-284.
21. Sadzuka Y., Hatakeyama H., Daimon T., Sonobe T. Screening of biochemical modulator by tumor cell permeability of doxorubicin. Int. J. Pharm. 2008, 354:63-69.
22. Sadzuka Y., Hatakeyama H., Sonobe T. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment. Int. J. Pharm. 2010, 383:186-191.
23. Sadzuka Y., Matsuura M., Sonobe T. The effect of taurine: a novel biochemical modulator, on the antitumor activity of doxorubicin. Biol. Pharm. Bull. 2009, 32:1584-1587.
24. Sadzuka Y., Mochizuki E., Iwazaki A., Hirota S., Takino Y. Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma-bearing mice. Biol. Pharm. Bull. 1995, 18:159-161.
25. Sadzuka Y., Mochizuki E., Takino Y. Mechanism of caffeine modulation of the antitumor activity of adriamycin. Toxicol. Lett. 1995, 75:39-49.
26. Sadzuka Y., Sonobe T. Anserine induced advantage effects on the antitumor activity of doxorubicin. Food Chem. Toxicol. 2007, 45:985-989.
27. Sadzuka Y., Sugiyama T., Miyagishima A., Nozawa Y., Hirota S. The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin. Cancer Lett. 1996, 105:203-209.
28. Sadzuka Y., Sugiyama T., Suzuki T., Sonobe T. Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol. Lett. 2001, 123:159-167.
29. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
30. Sugiyama T., Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer lett. 1998, 133:19-26.
31. Sugiyama T., Sadzuka Y. Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett. 2004, 212:117-184.
32. Sugiyama T., Sadzuka Y., Tanaka K., Sonobe T. Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin. Toxicol. Lett. 2001, 121:89-96.
33. Wang Q., Ding Z.H., Liu J.K., Zheng Y.T. Xanthohumol, a novel anti-HIV-1 agent purified from hops Humulus lupulus. Antiviral Res. 2004, 64:189-194.